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1. Introduction 
Two motives have combined to make me write a paper on headache in patients with 
pheochromocytoma. First, I would like to contribute to the clinical practices of both 
endocrinological clinicians who are working with patients with pheochromocytoma and 
neurologists who are performing headache consultations by elucidating the clinical 
characteristics of headache in patients with pheochromocytoma. Second, I will discuss the 
stereotypy of current diagnostic criteria provided by “The international classification of 
headache disorders,” 2nd edition (ICHDII)(1) by reviewing the literature concerning the 
mechanism of headache attributed to pheochromocytoma. 
Pheochromocytoma is a rare tumor arising from the chromaffin tissue. Although it is well-
known to produce catecholamine , the tumor is frequently disclosed incidentally by autopsy 
or adrenal imaging.(2)-(3) The representative clinical features are characterized by the 
pentad of symptoms known as the “5Hs”, that is headache, hypertension, hyperglycemia, 
hypermetabolism, and hyperhydrosis. Among these symptoms, which are attributed to the 
overproduction of catecholamine by the tumor, headache is important for four reasons. 
First, it is one of the most frequent symptoms.(4)(5)(6)(7) Second, it is frequently the 
presenting symptom.(8) Third, it may be the only symptom.(9)(10) Fourth, it may be the 
presenting symptom of a life-threatening disease with a histopathologically confirmed 
tumor.(11)(7) 
2. Clinical characteristics of headache attributed to pheochromocytoma 
Paroxysmal headache occurs in 51-80% of patients with pheochromocytoma. The most 
characteristic feature of the headache is its rapid onset. It nearly always seems to reach its 
peak within minutes, sometimes within one minute (thunderclap headache).(10)(12-14) It 
usually occurs spontaneously, but recurrent severe headaches may occur after voiding in 
patients with bladder pheochromocytoma.(13, 15) 
An important feature of the paroxysmal headache is its short duration. In 50% of patients it 
lasts for less than 15 minutes, and in 70% its duration is less than one hour.(4) However, in 
patients with migraine, it may last longer.(8) 
The headache was nearly always bilateral, (8) affecting any part of the head. The occipital, 
nuchal-occipital, and frontal-occipital regions are the predominant locations.(4) The 
headache is generally described as throbbing, pulsating, or bursting in quality, and is 
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moderately to very severe in intensity.(8) As in the other patients with pheochromocytoma, 
headaches are frequently associated with palpitation and perspiration. Other features 
include apprehension and/or anxiety, often with a sense of impending death, tremor, visual 
disturbances, abdominal or chest pain, nausea, vomiting, and occasionally paraesthesia. The 
face can blanch or flush during attack. 
The headaches are sometimes worse when lying down and sometimes made worse by 
moving.(8) Stress maneuvers such as coughing, sneezing, bending, and straining commonly 
aggravate the pain.(4) Measurement of blood pressure before and after onset of the 
headache revealed a sudden increase in both systolic and diastolic blood pressure.(8) 
3. Diagnosis of headache attributed to pheochromocytoma 
Diagnostic cues are usually provided by additional symptoms attributed to sympathetic 
activation, such as diaphoresis, palpitation, apprehension, and/or anxiety. The diagnosis is 
established by the demonstration of increased excretion of catecholamines or catecholamine 
metabolites, and can usually be verified by analysis of a single 24-hour urine sample 
collected when the patient is hypertensive or symptomatic. 
4. Differential diagnosis 
The typical case with the full-blown syndrome (5Hs) is not difficult to diagnose, but in some 
cases of pheochromocytoma, the symptoms are very subtle or absent except for severe 
headache. The most important point is to include pheochromocytoma in the differential 
diagnosis of a case with episodic headache. Further, careful history taking with close 
attention to sympathetic autonomic features will guide physicians to the right path. 
Development of radiology enables us to exclude most secondary headache disorders easily, 
but in all primary headaches and some secondary headaches, brain imaging studies reveal 
no changes. In the case of pheochromocytoma,  normal brain imaging is not the end but the 
starting point for the differential diagnosis. 
4.1 Cluster headache and other trigeminal autonomic cephalalgia 
Among the primary headaches, cluster headache is most similar to pheochromocytoma 
headache. An episodic pattern of occurrence, sudden onset, rapid evolution, short duration, 
and severity characterize both headaches. However, cluster headache is strictly unilateral 
and has parasympathetic autonomic system features, while pheochromocytoma headache is 
usually bilateral and has sympathetic autonomic system features. In addition to the 
difference in autonomic features, its unilaterality is also characteristic of cluster headache. 
Pain is usually more localized to the orbital area in patients with cluster headache. If these 
two diseases are confounded, highly critical outcomes may follow. In one reported cases, for 
example, dihydroergotamine, an agent sometimes used to treat cluster headache, was 
administered errorneously to a patient with pheochromocytoma, causing a hypertensive 
crisis and posterior reversible encephalopathy syndrome.(16) 
4.2 Migraine 
Because migraine is one of the commonest headache disorders, it is always included in the 
differential diagnosis of headache disorders. Classical migraine with aura will be no 
diagnostic problem, but a bilateral episodic headache without aura, should be differentiated 
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from other disorders, including pheochromocytoma. Particularly, if the history of headaches 
is short and their duration is brief, it will be a diagnostic challenge. Nausea is usually 
associated with both types of headache. Magnetic resonance imaging of the brain is useless 
in the differential diagnosis of these two. Careful history taking with particular attention to 
additional features, including scotoma, photophobia, and sympathetic autonomic symptoms 
reveals the correct diagnosis. 
4.3 Thunderclap headache (TCH) 
Thunderclap headache (TCH) is defined as a severe head pain with sudden onset, reaching 
its maximum intensity in less than 1 minute and lasting from 1 hour to 10 days. 
Subarachnoid hemorrhage is by far the most common   and most dangerous cause of 
thunderclap headache, but numerous other diseases involving the vasculature of the central 
nervous system, such as ischemic stroke, cerebral venous thrombosis, cervical arterial 
dissection, acute hypertensive crisis, retroclival hematoma, pituitary apoplexy, and the non-
vascular structures of the central nervous system, such as spontaneous intracranial 
hypotension, third ventricle colloid cyst, and intracranial infection are found on the list of 
the diseases to be excluded in the differential diagnosis. Therefore, TCH is a particularly 
important symptom in differential diagnosis by cranial imaging. However, it is also 
important to bear in mind that many other diseases associated with TCHs, such as 
pheochromocytoma(10, 12-14) and myocardial infarction, cannot be detected by cranial 
imaging and may have serious outcomes. 
4.4 Tension-type headache (TTH) 
Tension-type headache (TTH) is the most common type of primary headache, and its 
lifetime prevalence in the general population is estimated to be from 30% to 78%. TTH is 
subdivided into episodic and chronic subtypes. Episodic TTH is further subdivided into 
frequent and infrequent subtypes. Frequent episodic TTH may be a candidate for the 
diagnosis of pheochromocytoma. It is usually bilateral and non-throbbing in nature. The 
intensity of the headache is mild to moderate, and it is not aggravated by routine physical 
activity. It lacks nausea, vomiting, arterial hypertension, or other sympathetic autonomic 
features (palpitation, perspiration, pallor, tremor, or anxiety).  
4.5 Headache attributed to arterial hypertension 
Mild (140-159/90-99 mmHg) or moderate (160-179/100-109 mmHg) chronic arterial 
hypertension does not cause headache.(17) Ambulatory blood pressure monitoring in 
patients with mild to moderate hypertension has shown no convincing relationship between 
blood pressure fluctuations over a 24-hour period and the presence or absence of 
headache.(18) However, paroxysmal hypertension may cause headache. “Headache 
attributed to hypertensive crisis without hypertensive encephalopathy” is defined as a 
bilateral pulsating headache that may be precipitated by physical activity and associated 
with a hypertensive crisis. A hypertensive crisis is defined as a paroxysmal rise in systolic 
(to ≧180 mmHg) and/or diastolic (to ≧120 mmHg) blood pressure but without clinical 
features of hypertensive encephalopathy. Further, headache that develops during a 
hypertensive crisis should resolve within one hour after normalization of blood pressure.(1) 
The mechanism of this type of headache is not fully understood. Failure of baroreceptor 
reflexes (after carotid endarterectomy or subsequent to irradiation of the neck) is thought to 
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be a one of the mechanisms. Although it shows no sympathetic autonomic features, the rest 
of the characterisics of this headache are quite similar to pheochromocytoma headache. 
Again, it is important to ask the patient about their present and past history of sympathetic 
autonomic symptoms (palpitation, perspiration, pallor, tremor, or anxiety) and neck 
surgery. 
4.6 Intracranial pheochromocytoma 
Brain metastases of pheochromocytoma are extremely rare, and intracranial lesions are the 
only sites of metastasis in patients with adrenal pheochromocytoma. Mercuri et al. reported 
a primary meningeal pheochromocytoma that presented with headache, vomitting, and 
arterial hypertension.(19) Laboratory studies revealed high plasma catecholamines 
(norepinephrine and epinephrine). The tumor was resected, and histopathological 
examination confirmed the diagnosis. Six years follow-up after surgery showed that the 
patient was neurologically intact with normalized blood pressure and catecholamine values. 
This case is a very rare exception in which cranial imaging study provided the crucial 
information to make a diagnosis of headache attributed to pheochromocytoma. 
4.7 Spontaneous intracranial hemorrhage due to pheochromocytoma 
Park et al. reported an 18-year-old man who presented with a sudden onset of headaches, 
followed by left hemianopsia.(20) He had experienced palpitations and chest discomfort 
during physical exertion for two years prior to admission. A brain CT scan showed 
intracerebral hemorrhage in the left frontoparietal area. Hypertension in the form of 
paroxysmal attacks led the authors to suspect pheochromocytoma. Evaluation of a 24-h 
urine specimen showed elevated vanillylmandelic acid and metanephrine levels. 
Abdominal CT demonstrated a para-aortic mass, and 131I-metaiodobenzylguanidine (MIBG) 
scintigraphy showed high uptake in the same area. This case typically showed that cranial 
imaging is useless to make a correct diagnosis of headache caused by pheochromocytoma. 
4.8 Pheochromocytoma crisis induced by glucocorticoids 
Pheochromocytoma crisis (PC) is a rare life-threatening endocrineological emergency that 
may present spontaneously or can be elicited by triggers, including certain medications that 
trigger the release of catecholamines by tumors. Acute and rapidly progressive 
hemodynamic disturbances result from the actions of high quantities of catecholamines 
secreted by the tumor. Hypertensive crisis, cardiac ischemia, cardiogenic shock, and end-
organ failure may occur. Some patients show headache concomitant with hypertension. 
Many drugs can cause adverse reactions in patients with pheochromocytoma, but we also 
have to keep in mind that a high-dose dexamethasone suppression test (DST) may 
precipitate PC in cases with incidental adrenal masses.(21) 
5. Headache and hypertension 
Recording of blood pressure before and after the onset of the headache revealed a sudden 
increase in both systolic and diastolic blood pressure.(8) Probably because of this single sign, 
the diagnostic criteria proposed in “The international classification of headache disorders, 
2nd edition (ICHD-II)” included concomitant hypertension as a mandatory item for the 
diagnosis of headache attributed to pheochromocytoma.(1) However, in some patients, very 
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high blood pressures were observed without concomitant headache.(8) In addition, 
observation of normal or low blood pressure in pheochromocytoma cases is not particularly 
rare,(22) and it is known that catecholamine concentrations in circulating blood are not well 
correlated with blood pressure. There were other cases in which hypertension was not 
observed despite confirmation of urinary cathecholamine metabolite elevation.(23) 
6. Mechanism of headache in patients with pheochromocytoma 
The mechanism of headache associated with pheochromocytoma is not fully understood. 
According to the International Classification of Headache Disorders; 2nd Edition (ICHDII), 
the diagnosis of headache attributed to pheochromocytoma is established by fulfillment of 
the following two conditions. First, headache develops concomitantly with an abrupt rise in 
blood pressure. Second, headache resolves or markedly improves within 1 hour of 
normalization of blood pressure. However, not a small number of patients who were 
demonstrated to have pheochromocytoma by biochemical or radiological examination 
and/or histopathological findings of their surgical specimens showed typical headache 
without hypertension.(14, 23) Therefore, hypertension is not the only factor in headache 
pathogenesis.(24)  
6.1 Catecholamines and headache 
The human cerebral circulation is innervated by sympathetic nerves. The sympathetic 
system contains the transmitters noradrenaline, neuropeptide Y (NPY), and possibly 
adenosinetriphosphate (ATP) and is a vasoconstrictor pathway.(25) The cranial vessels are 
also innervated by the trigeminal nerve. This system is marked by the presence of calcitonin 
gene-related peptide (CGRP), substance P, and neurokinin A. It is a vasodilator pathway(26) 
via antidromic release upon activation as well as having a primary involvement in sensory 
function.(27) 
It is hardly possible to connect throbbing headache with the direct action of the strong 
vasopressor, noradrenalin, which usually causes hypertension in patients with 
pheochromocytoma. Lance et al. studied the relationship between the main subtype of 
catecholamine produced by the pheochromocytoma and clinical symptoms of patients. They 
concluded that the presence or absence of headache or quality of the headache did not bear 
any relationship to the ratio of norepinephrine to epinephrine secreted.(8) Intravenous 
infusion of norepinephrine into a patient susceptible to migraine at a sufficient 
concentration to raise the systolic blood pressure 10 to 40 mmHg is not sufficient to produce 
headache. Wolff et al. administered such infusions on 116 occasions to 35 patients with 
vascular headaches of the migraine type, with abolition or reduction in intensity of 
headache in 93 instances. In these cases, the diameter of the temporal artery and the 
amplitude of its pulse wave were observed to diminish as the headache abated.  
6.2 Neuropeptides and headache 
It seems quite plausible that strong vasodilator peptides produced by pheochromocytoma, 
such as adrenomedullin(28) and  CGRP(23) can cause episodic vascular headaches 
characterized by throbbing in patients with pheochromocytoma. The headache-inducing 
property of CGRP has been studied in one double-blind controlled trial.(29) The headache 
was pulsating in quality and resolved within 1 hour after ingestion of CGRP. In addition, a 
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recent study showed that a CGRP antagonist is effective in the acute treatment of 
migraine.(30) To elucidate a possible role of CGRP in the pathological mechanism of 
pheochromocytoma headache, a trial using a CGRP antagonist in patients with 
pheochromocytoma headache should be performed. 
7. Conclusion 
It is very important to understand the characteristics of the headache attributed to 
pheochromocytoma because it is one of the most frequent symptoms of a disease that is 
frequently neglected clinically. It is also important to consider during headache consultation 
because both neurological and radiological examinations of the brain will provide little 
information for the correct diagnosis. 
The mechanism of the headache in patients with pheochromocytoma is not fully 
understood. In addition to the arterial hypertension, vasodilator peptides produced by the 
tumor may play important roles. 
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